Evidence map›Paper›PMID 42710004›Full record

ArticleJMIR public health and surveillance2026

Indications for Medical Cannabis and Their Alignment With US-Wide Disease Prevalences in the US' Largest Medical Cannabis Program: Cross-Sectional Study.

Sebastian Jugl, Nicole E Smolinski, Tansu Miriam Işılay Aydoğan, Almut G Winterstein

Abstract read
In one paragraph

Article in JMIR public health and surveillance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sebastian JuglDepartment of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, 6018 Malachowsky Hall, Gainesville, FL, United States, 1 352-273-6268.ORCID 0000-0002-1244-1423
Nicole E SmolinskiDepartment of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, 6018 Malachowsky Hall, Gainesville, FL, United States, 1 352-273-6268.ORCID 0000-0002-0866-4579
Tansu Miriam Işılay AydoğanDepartment of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, 6018 Malachowsky Hall, Gainesville, FL, United States, 1 352-273-6268.ORCID 0009-0006-9688-8981
Almut G WintersteinDepartment of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, 6018 Malachowsky Hall, Gainesville, FL, United States, 1 352-273-6268.ORCID 0000-0002-6518-5961

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Unlabelled: This research letter compared the prevalence of qualifying conditions among patients certified to use medical cannabis in Florida to population-based prevalence estimates for the same conditions and observed marked discrepancies. These findings highlight conditions that appear to be significant reasons for patients to consider medical cannabis, providing important research priorities for future research on its effectiveness and safety.

Indexed as

Medical MarijuanaCross-Sectional StudiesFloridaHumansPrevalenceUnited StatesMedical Marijuanacannabiscross-sectional studiesmedical marijuanamedical marijuana use registryprevalencequalifying condition

Identifiers

PMID42710004
PMCPMC13552832

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.